Cargando…
Identification a novel mononucleotide deletion mutation in GAA in pompe disease patients
BACKGROUND: Mutations in the acid alpha-glucosidase (GAA) gene usually lead to reduced GAA activity. In this study, we analyzed the mutations of GAA and GAA enzyme activity from one sibling suspected Pompe disease and their first-degree relatives. MATERIALS AND METHODS: In this cross-sectional study...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583621/ https://www.ncbi.nlm.nih.gov/pubmed/28900456 http://dx.doi.org/10.4103/jrms.JRMS_874_16 |
_version_ | 1783261353003188224 |
---|---|
author | Ebrahimi, Milad Behnam, Mahdieh Behranvand-jazi, Nafiseh Yari, Ladan Sheikh-kanlomilan, Sajad Salehi, Mansoor Tahmasebi, Pardis Amini, Mohaddeseh Behjati, Mohaddeseh Hosseini, Nafisehsadat |
author_facet | Ebrahimi, Milad Behnam, Mahdieh Behranvand-jazi, Nafiseh Yari, Ladan Sheikh-kanlomilan, Sajad Salehi, Mansoor Tahmasebi, Pardis Amini, Mohaddeseh Behjati, Mohaddeseh Hosseini, Nafisehsadat |
author_sort | Ebrahimi, Milad |
collection | PubMed |
description | BACKGROUND: Mutations in the acid alpha-glucosidase (GAA) gene usually lead to reduced GAA activity. In this study, we analyzed the mutations of GAA and GAA enzyme activity from one sibling suspected Pompe disease and their first-degree relatives. MATERIALS AND METHODS: In this cross-sectional study, GAA enzyme activity assay was assessed using tandem mass spectrometry. Polymerase chain reaction and Sanger sequencing were performed for GAA analysis. RESULTS: GAA enzyme activity was significantly decreased in patients compared to the normal range (P = 0.02). Two individuals showed ten alterations in the GAA sequence, in which one of them (c. 1650del G) has not been previously described in the literature. A single Guanine deletion (del-G) was detected at codon 551 in exon 12. CONCLUSION: According to the literature, the detected change is a novel mutation. We hypothesized that the discovered deletion in the GAA might lead to a reduced activity of the gene product. |
format | Online Article Text |
id | pubmed-5583621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-55836212017-09-12 Identification a novel mononucleotide deletion mutation in GAA in pompe disease patients Ebrahimi, Milad Behnam, Mahdieh Behranvand-jazi, Nafiseh Yari, Ladan Sheikh-kanlomilan, Sajad Salehi, Mansoor Tahmasebi, Pardis Amini, Mohaddeseh Behjati, Mohaddeseh Hosseini, Nafisehsadat J Res Med Sci Short Communication BACKGROUND: Mutations in the acid alpha-glucosidase (GAA) gene usually lead to reduced GAA activity. In this study, we analyzed the mutations of GAA and GAA enzyme activity from one sibling suspected Pompe disease and their first-degree relatives. MATERIALS AND METHODS: In this cross-sectional study, GAA enzyme activity assay was assessed using tandem mass spectrometry. Polymerase chain reaction and Sanger sequencing were performed for GAA analysis. RESULTS: GAA enzyme activity was significantly decreased in patients compared to the normal range (P = 0.02). Two individuals showed ten alterations in the GAA sequence, in which one of them (c. 1650del G) has not been previously described in the literature. A single Guanine deletion (del-G) was detected at codon 551 in exon 12. CONCLUSION: According to the literature, the detected change is a novel mutation. We hypothesized that the discovered deletion in the GAA might lead to a reduced activity of the gene product. Medknow Publications & Media Pvt Ltd 2017-08-16 /pmc/articles/PMC5583621/ /pubmed/28900456 http://dx.doi.org/10.4103/jrms.JRMS_874_16 Text en Copyright: © 2017 Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Short Communication Ebrahimi, Milad Behnam, Mahdieh Behranvand-jazi, Nafiseh Yari, Ladan Sheikh-kanlomilan, Sajad Salehi, Mansoor Tahmasebi, Pardis Amini, Mohaddeseh Behjati, Mohaddeseh Hosseini, Nafisehsadat Identification a novel mononucleotide deletion mutation in GAA in pompe disease patients |
title | Identification a novel mononucleotide deletion mutation in GAA in pompe disease patients |
title_full | Identification a novel mononucleotide deletion mutation in GAA in pompe disease patients |
title_fullStr | Identification a novel mononucleotide deletion mutation in GAA in pompe disease patients |
title_full_unstemmed | Identification a novel mononucleotide deletion mutation in GAA in pompe disease patients |
title_short | Identification a novel mononucleotide deletion mutation in GAA in pompe disease patients |
title_sort | identification a novel mononucleotide deletion mutation in gaa in pompe disease patients |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583621/ https://www.ncbi.nlm.nih.gov/pubmed/28900456 http://dx.doi.org/10.4103/jrms.JRMS_874_16 |
work_keys_str_mv | AT ebrahimimilad identificationanovelmononucleotidedeletionmutationingaainpompediseasepatients AT behnammahdieh identificationanovelmononucleotidedeletionmutationingaainpompediseasepatients AT behranvandjazinafiseh identificationanovelmononucleotidedeletionmutationingaainpompediseasepatients AT yariladan identificationanovelmononucleotidedeletionmutationingaainpompediseasepatients AT sheikhkanlomilansajad identificationanovelmononucleotidedeletionmutationingaainpompediseasepatients AT salehimansoor identificationanovelmononucleotidedeletionmutationingaainpompediseasepatients AT tahmasebipardis identificationanovelmononucleotidedeletionmutationingaainpompediseasepatients AT aminimohaddeseh identificationanovelmononucleotidedeletionmutationingaainpompediseasepatients AT behjatimohaddeseh identificationanovelmononucleotidedeletionmutationingaainpompediseasepatients AT hosseininafisehsadat identificationanovelmononucleotidedeletionmutationingaainpompediseasepatients |